+36.1%
MRNA vs PNC
+131.1%
-95.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.5% | +4.9% | +5.2% |
| 7D | -1.1% | -0.6% | -0.5% | -0.9% |
| 30D | +126.1% | -4.4% | +130.5% | +128.6% |
| 3M | +190.0% | +5.2% | +184.8% | +175.8% |
| 6M | +157.2% | +20.6% | +136.6% | +123.7% |
| YTD | +388.2% | +19.8% | +368.4% | +323.0% |
| 1Y | +467.0% | +24.4% | +442.6% | +377.9% |
| 3Y | +36.1% | +131.2% | -95.2% | -21.5% |
| All | +36.1% | +131.1% | -95.0% | -21.5% |
Cumulative growth
Daily Returns
Daily percentage return beside PNC.
Daily Out/Under-Performance
Portfolio return minus PNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling